Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

CNS 261Sarcoma 6Lymphoid 4Other hematologic neoplasm 3Breast 3Thoracic 2Head & Neck 2Genitourinary 2Gastrointestinal 2Endocrine 2Classical hematology 2Dermatologic 1

Conditions

Neoplasms 68Venous Thromboembolism 60Anemia 33Leukemia, Myeloid, Acute 28Anemia, Sickle Cell 26Multiple Myeloma 25Hematologic Neoplasms 25Myelodysplastic Syndromes 24Febrile Neutropenia 24Leukemia 22Lymphoma 19Anemia, Aplastic 19Thrombocytopenia 17Myeloproliferative Disorders 16Breast Neoplasms 16Anemia, Refractory, with Excess of Blasts 16Neutropenia 14Venous Thrombosis 13Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 12Lung Neoplasms 12Hodgkin Disease 12Fanconi Anemia 12Colorectal Neoplasms 12Ovarian Neoplasms 11Leukemia, Lymphocytic, Chronic, B-Cell 10Thrombosis 9Pulmonary Embolism 9Pancreatic Neoplasms 9

Interventions

Temozolomide 1Radiotherapy 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Glioma × Classical hematology × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

NCT00201903 2017-04-06

The Roles of Tissue Factor in Malignant Gliomas

Ontario Clinical Oncology Group (OCOG)

Completed
30 enrolled
CNSClassical hematology

Brain Neoplasms, Glioma, Thrombosis, Disease Progression, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡